These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1326362)

  • 21. Characterization of thyroid hormone binding to apolipoprotein-E: localization of the binding site in the exon 3-coded domain.
    Benvenga S; Cahnmann HJ; Robbins J
    Endocrinology; 1993 Sep; 133(3):1300-5. PubMed ID: 8365370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of thyroid hormone receptors in human IM-9 lymphocytes.
    Barlow JW; De Nayer P
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):327-32. PubMed ID: 3381637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-function relationship of the inhibition of the 3,5,3'-triiodothyronine binding to the alpha1- and beta1-thyroid hormone receptor by amiodarone analogs.
    van Beeren HC; Bakker O; Wiersinga WM
    Endocrinology; 1996 Jul; 137(7):2807-14. PubMed ID: 8770901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of thyroid hormones in vivo by hepatic nuclei of Rana catesbeiana tadpoles.
    Galton VA
    Endocrinology; 1980 Mar; 106(3):859-66. PubMed ID: 6243554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferential inhibition of cytoplasmic T3 binding is associated with reduced nuclear binding in cultured cells.
    Barlow JW; Raggatt LE; Scholz GH; Loidl NM; Blok RB; Topliss DJ; Stockigt JR
    Thyroid; 1996 Feb; 6(1):47-51. PubMed ID: 8777384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of iopanoic acid on thyroid hormone receptor, growth hormone production, and triiodothyronine generation from thyroxine in pituitary GH1 cells.
    Pascual A; Montiel F; Aranda A
    Endocrinology; 1987 Mar; 120(3):1089-96. PubMed ID: 3803311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of endogenous iodothyronines to isolated liver cell nuclei.
    Smith HC; Robinson SE; Eastman CJ
    Endocrinology; 1980 Apr; 106(4):1133-6. PubMed ID: 6244141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active and inactive forms of 3,5,3'-triiodo-L-thyronine (T3)-binding protein in rat kidney cytosol: possible role of nicotinamide adenine dinucleotide phosphate in activation of T3 binding.
    Hashizume K; Kobayashi M; Miyamoto T
    Endocrinology; 1986 Aug; 119(2):710-9. PubMed ID: 3015555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration and some properties of cytosol-binding proteins for thyroxine and triiodothyronine in human liver.
    Hamada S; Fukase M
    J Clin Endocrinol Metab; 1976 Feb; 42(2):302-8. PubMed ID: 4465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of thyroxine and triiodothyronine by nuclei of isolated tadpole liver cells.
    Kistler A; Yoshizato K; Frieden E
    Endocrinology; 1975 Oct; 97(4):1036-42. PubMed ID: 1081451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease in triiodothyronine binding sites in chick embryo erythrocytes during early development.
    Dasmahapatra AK; Thomas CR; Frieden E
    Dev Biol; 1987 Apr; 120(2):412-7. PubMed ID: 3556762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the binding of thyroxine to high density lipoproteins and apolipoproteins A-I.
    Benvenga S; Cahnmann HJ; Gregg RE; Robbins J
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1067-72. PubMed ID: 2498379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial euthyroid thyroxine excess: characterization of abnormal intermediate affinity thyroxine binding to albumin.
    Barlow JW; Csicsmann JM; White EL; Funder JW; Stockigt JR
    J Clin Endocrinol Metab; 1982 Aug; 55(2):244-50. PubMed ID: 6806311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone beta 1-receptor protein.
    Bakker O; van Beeren HC; Wiersinga WM
    Endocrinology; 1994 Apr; 134(4):1665-70. PubMed ID: 8137729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular uptake of 3,5,3'-triiodothyronine and thyroxine by red blood and thymus cells.
    Galton VA; St Germain DL; Whittemore S
    Endocrinology; 1986 May; 118(5):1918-23. PubMed ID: 3486116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereospecificity of triiodothyronine transport into brain, liver, and salivary gland: role of carrier- and plasma protein-mediated transport.
    Terasaki T; Pardridge WM
    Endocrinology; 1987 Sep; 121(3):1185-91. PubMed ID: 3622378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of hepatic low Km iodothyronine 5'-monodeiodinase.
    Boado RJ; Chopra IJ
    Endocrinology; 1989 May; 124(5):2245-51. PubMed ID: 2707154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of nuclear 3,5,3'-triiodothyronine-binding sites in fetal human lung.
    Gonzales LW; Ballard PL
    J Clin Endocrinol Metab; 1981 Jul; 53(1):21-8. PubMed ID: 6263937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells.
    Everts ME; Visser TJ; Moerings EP; Docter R; van Toor H; Tempelaars AM; de Jong M; Krenning EP; Hennemann G
    Endocrinology; 1994 Dec; 135(6):2700-7. PubMed ID: 7988460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cholecystographic agents and sulfobromophthalein on binding of thyroid hormones to serum proteins.
    Felicetta JV; Green WL; Huber-Smith MJ
    J Clin Endocrinol Metab; 1983 Jul; 57(1):207-12. PubMed ID: 6853679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.